AC Immune raises CHF 20 million and initiates world's first anti-pTau vaccine trial for Alzheimer's disease Jan 9, 2014 English 171.3 KB Français 163.3 KB Deutsch 175.8 KB CHF 20 million round D secured from existing investors World's first Alzheimer's vaccine trial against phospho-Tau hallmark